No, since the trial was blinded to both patients and physicians, it would be impossible for anyone to guess what the trial outcome might be. Only the DSMB should have access to unblinded data to do the interim analysis. That is the whole point of doing it this way.
- Forums
- ASX - By Stock
- MSB
- Novartis deal on the rocks
Novartis deal on the rocks, page-102
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.20 |
Change
0.010(0.84%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.18 | $1.20 | $1.18 | $540.8K | 456.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 42849 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 269196 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 660 | 1.185 |
5 | 16725 | 1.180 |
4 | 28838 | 1.175 |
10 | 55008 | 1.170 |
5 | 116399 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 10388 | 7 |
1.195 | 27227 | 6 |
1.200 | 273252 | 25 |
1.205 | 14650 | 2 |
1.210 | 14800 | 4 |
Last trade - 10.15am 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |